Description

Pinealon 20mg – EDR Bioregulator Research Peptide

Pinealon 20mg is a synthetic tripeptide investigated in scientific studies involving neuronal cell biology, oxidative stress, cellular signalling and peptide bioregulation. Also identified as the EDR peptide, Pinealon contains three amino acids arranged in the sequence Glu-Asp-Arg.

This short peptide has attracted interest in experimental neuroscience because researchers have examined its interactions with cells exposed to oxidative and metabolic stress. Published studies have explored cellular viability, reactive oxygen species and possible mechanisms of gene regulation.

For laboratories studying short regulatory peptides, Pinealon 20mg represents a compound with an established molecular identity and a developing, predominantly preclinical research literature.

What Is Pinealon 20mg?

Pinealon is a synthetic peptide consisting of glutamic acid (Glu), aspartic acid (Asp) and arginine (Arg). Its amino acid sequence is commonly abbreviated EDR.

The peptide was investigated as part of the Khavinson short peptide bioregulator research programme, which examined how small amino acid sequences interact with biological systems.

Pinealon is particularly associated with experiments involving neuronal cells, oxidative stress responses and cellular regulatory mechanisms.

The 20mg designation refers to the labelled quantity of peptide material. It does not represent a recommended human dose or establish pharmaceutical suitability.

Pinealon 20mg Product Specifications

• Product Name: Pinealon 20mg
• Alternative Name: EDR Peptide
• Amino Acid Sequence: Glu-Asp-Arg
• Peptide Classification: Synthetic tripeptide
• Labelled Quantity: 20mg
• Molecular Formula: C15H26N6O8 (free peptide)
• Approximate Molecular Weight: 418.40 g/mol (free peptide)
• Research Category: Short peptide bioregulation
• Research Focus: Neuronal cell biology, oxidative stress and cellular signalling
• Purity: Confirm using batch-specific analytical documentation
• Storage: Follow verified manufacturer instructions

Understanding the Pinealon EDR Peptide Structure

The abbreviation EDR represents the three amino acids that form Pinealon:

• E – Glutamic Acid: An amino acid involved in numerous biological processes.
• D – Aspartic Acid: An amino acid present in many naturally occurring proteins and peptides.
• R – Arginine: An amino acid containing a positively charged side chain under many physiological conditions.

These residues are linked by peptide bonds to form a short tripeptide structure.

Scientists investigate the properties of Pinealon to understand whether short amino acid sequences can influence cellular responses under defined experimental conditions.

Scientific Research Into Pinealon 20mg

1. Oxidative Stress Research

One of the best documented research areas involving Pinealon concerns oxidative stress.

Oxidative stress develops when reactive oxygen species accumulate beyond the capacity of a biological system to regulate them effectively.

A published laboratory investigation examined Pinealon in cerebellar granule cells, neutrophils and PC12 cells exposed to experimental oxidative stress.

The researchers reported reduced accumulation of reactive oxygen species and changes in cell survival measurements under the conditions studied.

These observations provide evidence of biological activity in laboratory models but do not establish antioxidant benefits in humans.

2. Neuronal Cell Viability

Pinealon has also been studied for its effects on neuronal cell survival in experimental systems.

In cell culture research, scientists can expose neurons to controlled stress conditions and evaluate changes in cell viability, signalling pathways and markers of cellular damage.

Some experiments involving Pinealon have reported reduced markers of cell death.

These findings are relevant to basic neuroscience research, although they cannot be interpreted as proof that Pinealon prevents neurological injury or disease in people.

3. ERK1/2 Signalling Research

The extracellular signal-regulated kinase pathways, commonly called ERK1 and ERK2, are involved in cellular responses associated with growth, differentiation and survival.

Published Pinealon research has described changes in the timing of ERK1/2 activation in experimental cell systems.

Investigating these responses may help scientists understand how short peptides interact with cellular signalling networks.

The clinical significance of these laboratory findings remains uncertain.

4. Peptide and Gene Regulation Research

Another area of Pinealon research concerns possible interactions between short peptides and components involved in gene regulation.

Experimental and molecular studies have investigated whether Pinealon can interact with DNA and influence selected cellular processes.

These investigations have generated hypotheses about the biological activities of short peptide bioregulators.

However, demonstrating molecular interactions in laboratory systems does not establish that Pinealon produces predictable gene-regulatory effects in humans.

5. Experimental Cognitive and Neurological Research

Pinealon has appeared in preclinical investigations involving neuronal stress, learning-related outcomes and experimental models of neurological dysfunction.

Animal studies can provide useful information about biological mechanisms and help researchers identify questions for future investigation.

However, results from animal models cannot be assumed to predict human cognitive outcomes.

There is insufficient reliable controlled human evidence to establish Pinealon as a memory enhancer or treatment for neurological conditions.

Pinealon 20mg and Cellular Ageing Research

Pinealon is sometimes discussed in the context of cellular ageing because oxidative stress and cellular regulation are important subjects in ageing biology.

Researchers have investigated whether short peptides influence cellular responses associated with biological ageing.

Although some preliminary experiments suggest effects on selected cellular markers, there is no reliable clinical evidence demonstrating that Pinealon slows human ageing or extends lifespan.

Terms such as anti-ageing peptide or neuroprotective peptide should therefore be understood as descriptions of research interests rather than proven clinical outcomes.

Pinealon 20mg vs Pinealon 5mg

Pinealon 20mg and Pinealon 5mg refer to products labelled with different quantities of the same EDR tripeptide.

Both designations are associated with the Glu-Asp-Arg amino acid sequence.

The difference in labelled quantity does not establish differences in effectiveness, safety or clinical suitability.

Researchers should compare verified product identity, molecular form, analytical documentation and intended laboratory requirements rather than assuming that a larger labelled quantity produces a stronger biological effect.

Pinealon vs Epitalon: Key Research Differences

Pinealon and Epitalon are distinct synthetic peptides investigated within the broader field of peptide bioregulation.

• Pinealon: A tripeptide with the sequence Glu-Asp-Arg (EDR), investigated primarily in neuronal and oxidative stress research.
• Epitalon: A tetrapeptide with the sequence Ala-Glu-Asp-Gly (AEDG), investigated in separate research involving cellular ageing and telomerase-related mechanisms.

Although both belong to the broader category of short synthetic peptides, their chemical structures and research findings are not interchangeable.

Understanding the Pinealon 20mg Label

The 20mg designation identifies the labelled quantity of peptide material associated with the product.

It does not independently verify purity, chemical identity, sterility, formulation or suitability for a particular laboratory procedure.

Researchers should consult manufacturer documentation to confirm the actual composition and quality of the material supplied.

Research Quality and Product Documentation

Important considerations when evaluating Pinealon 20mg research material include:

• Confirmation of the Glu-Asp-Arg peptide sequence
• Verified chemical identity and molecular form
• Batch-specific certificate of analysis
• Analytical purity testing
• Accurate labelled peptide quantity
• Manufacturer and batch traceability
• Packaging integrity
• Product-specific storage and stability information
• Clearly stated intended-use restrictions

These factors help laboratories evaluate research material without relying on unsupported claims about pharmaceutical quality or performance.

Storage and Handling of Pinealon Research Material

Pinealon research material should be stored according to verified manufacturer instructions and the available stability data.

Storage requirements can vary according to the peptide’s physical form, formulation, packaging and environmental conditions.

Researchers should not assume that all Pinealon products require identical storage temperatures or handling procedures.

Pinealon Safety and Research Limitations

Pinealon remains an investigational peptide with limited reliable human clinical evidence.

Its long-term safety, pharmacokinetics, therapeutic effectiveness and appropriate clinical applications have not been adequately established.

Laboratory findings involving oxidative stress and neuronal cell viability do not demonstrate that Pinealon prevents dementia, improves memory, treats neurological disease or reverses ageing.

Pinealon is not an established FDA- or EMA-approved medicine for cognitive enhancement, neurological disorders or anti-ageing treatment.

This information is intended for scientific and educational purposes and does not provide medical advice, human dosing recommendations or administration instructions.

Frequently Asked Questions About Pinealon 20mg

What is Pinealon 20mg?

Pinealon 20mg is a product listing for a synthetic tripeptide identified by the sequence Glu-Asp-Arg, commonly abbreviated EDR.

What does EDR stand for?

EDR represents glutamic acid, aspartic acid and arginine, the three amino acids forming Pinealon.

What is Pinealon researched for?

Pinealon has been investigated in studies involving neuronal cell biology, oxidative stress, cellular signalling and peptide bioregulation.

Does Pinealon improve memory?

Preclinical research has explored neurological and learning-related outcomes, but reliable controlled human evidence is insufficient to establish memory-enhancing benefits.

Is Pinealon an anti-ageing peptide?

Pinealon is investigated within the field of cellular ageing and peptide bioregulation, but it has not been clinically proven to slow human ageing.

What is the difference between Pinealon 20mg and 5mg?

The two labels describe different quantities of the same EDR peptide. They do not establish differences in clinical effectiveness or safety.

Is Pinealon the same as GHK-Cu?

No. Pinealon is the Glu-Asp-Arg tripeptide, while GHK-Cu is a copper complex of the Gly-His-Lys peptide. They have different chemical structures and research applications.

Is Pinealon approved for medical use?

Pinealon is not an established FDA- or EMA-approved medicine for neurological or anti-ageing indications.

Does Pinealon 20mg mean a recommended dose?

No. The 20mg designation refers to the labelled quantity of material, not a recommended dose or an established clinical regimen.

Pinealon 20mg – Product Summary

Pinealon 20mg is a synthetic EDR tripeptide associated with scientific research into neuronal cell biology, oxidative stress, cellular signalling and peptide bioregulation.

Its compact molecular structure and reported biological activity in experimental systems have made it a subject of continuing preclinical investigation.

Researchers should verify peptide identity, purity, formulation, batch documentation and storage requirements before selecting Pinealon 20mg for laboratory research.